2-(2-cresyl)-4h-1-3-2-benzodioxaphosphorin-2-oxide has been researched along with Encephalopathy, Toxic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapleau, M; Cool, DR; Garrett, TL; Joshi, K; Lucot, JB; Rapp, CM; Schlager, JJ | 1 |
Garrett, TL; Grubbs, RD; Lucot, JB; Rapp, CM; Schlager, JJ | 1 |
Carletti, E; Colletier, JP; Froment, MT; Lockridge, O; Masson, P; Nachon, F; Schopfer, LM; Weik, M | 1 |
3 other study(ies) available for 2-(2-cresyl)-4h-1-3-2-benzodioxaphosphorin-2-oxide and Encephalopathy, Toxic
Article | Year |
---|---|
The effects of 8-OH-DPAT on neuroinflammation after sarin exposure in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apoptosis; Behavior, Animal; Brain; Cholinesterases; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxicity Syndromes; Organophosphorus Compounds; Sarin; Serotonin Receptor Agonists; Survival Analysis; Weight Loss | 2013 |
A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
Topics: Acetylcholinesterase; Animals; Carboxylesterase; Chemical Warfare Agents; Cholinesterases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Glial Fibrillary Acidic Protein; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuroglia; Neurotoxicity Syndromes; Organophosphorus Compounds; Sarin; Seizures; Time Factors | 2010 |
Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
Topics: Acetylcholinesterase; Air Pollution, Indoor; Aircraft; Butyrylcholinesterase; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Kinetics; Mass Spectrometry; Models, Molecular; Neurotoxicity Syndromes; Organophosphorus Compounds; Peripheral Nervous System Diseases | 2011 |